X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA J.B.CHEMICALS AJANTA PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 19.6 13.3 147.0% View Chart
P/BV x 4.5 2.1 213.4% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 AJANTA PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-18
J.B.CHEMICALS
Mar-16
AJANTA PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs1,818318 571.5%   
Low Rs1,106200 554.4%   
Sales per share (Unadj.) Rs239.5148.0 161.8%  
Earnings per share (Unadj.) Rs52.819.1 276.6%  
Cash flow per share (Unadj.) Rs59.523.9 248.5%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs230.0128.9 178.3%  
Shares outstanding (eoy) m88.7784.82 104.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.11.7 349.1%   
Avg P/E ratio x27.713.6 204.2%  
P/CF ratio (eoy) x24.610.8 227.3%  
Price / Book Value ratio x6.42.0 316.8%  
Dividend payout %02.6 0.0%   
Avg Mkt Cap Rs m129,78221,951 591.2%   
No. of employees `0006.82.7 248.5%   
Total wages/salary Rs m3,7651,841 204.5%   
Avg. sales/employee Rs Th3,128.44,590.9 68.1%   
Avg. wages/employee Rs Th554.0673.4 82.3%   
Avg. net profit/employee Rs Th689.7592.1 116.5%   
INCOME DATA
Net Sales Rs m21,25812,551 169.4%  
Other income Rs m242542 44.6%   
Total revenues Rs m21,49913,093 164.2%   
Gross profit Rs m6,5842,055 320.4%  
Depreciation Rs m596412 144.5%   
Interest Rs m496 4.3%   
Profit before tax Rs m6,2262,088 298.1%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,539469 328.1%   
Profit after tax Rs m4,6861,619 289.5%  
Gross profit margin %31.016.4 189.2%  
Effective tax rate %24.722.5 110.1%   
Net profit margin %22.012.9 170.9%  
BALANCE SHEET DATA
Current assets Rs m12,2367,778 157.3%   
Current liabilities Rs m3,4614,358 79.4%   
Net working cap to sales %41.327.2 151.5%  
Current ratio x3.51.8 198.1%  
Inventory Days Days6055 110.1%  
Debtors Days Days8480 105.6%  
Net fixed assets Rs m11,1405,713 195.0%   
Share capital Rs m177170 104.3%   
"Free" reserves Rs m20,23710,547 191.9%   
Net worth Rs m20,41410,937 186.6%   
Long term debt Rs m100-   
Total assets Rs m24,48615,574 157.2%  
Interest coverage x1,519.422.8 6,658.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.8 107.7%   
Return on assets %19.211.0 174.0%  
Return on equity %23.014.8 155.1%  
Return on capital %30.520.0 152.8%  
Exports to sales %048.7 0.0%   
Imports to sales %07.1 0.0%   
Exports (fob) Rs mNA6,115 0.0%   
Imports (cif) Rs mNA889 0.0%   
Fx inflow Rs m11,6676,169 189.1%   
Fx outflow Rs m1,6161,285 125.7%   
Net fx Rs m10,0524,884 205.8%   
CASH FLOW
From Operations Rs m2,8541,397 204.4%  
From Investments Rs m-2,604-320 813.0%  
From Financial Activity Rs m-2-1,196 0.2%  
Net Cashflow Rs m248-102 -242.5%  

Share Holding

Indian Promoters % 73.8 55.4 133.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 1.6 3.4 45.7%  
FIIs % 7.6 3.9 194.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 37.0 45.9%  
Shareholders   20,968 30,437 68.9%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   MERCK LTD  CIPLA  TORRENT PHARMA  SUVEN LIFE  WYETH LTD  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jun 21, 2018 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS